Connect Biopharma Holdings Limited
CNTB
$2.55
$0.010.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1,537.87% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1,537.87% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 1,537.87% | -- | |||
| SG&A Expenses | -13.63% | 11.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.01% | 27.37% | |||
| Operating Income | 10.22% | -26.28% | |||
| Income Before Tax | 10.99% | -28.30% | |||
| Income Tax Expenses | 25.00% | 77.78% | |||
| Earnings from Continuing Operations | 10.90% | -28.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.90% | -28.39% | |||
| EBIT | 10.22% | -26.28% | |||
| EBITDA | 10.29% | -26.71% | |||
| EPS Basic | 19.88% | -27.31% | |||
| Normalized Basic EPS | 19.96% | -27.25% | |||
| EPS Diluted | 19.88% | -27.31% | |||
| Normalized Diluted EPS | 19.96% | -27.25% | |||
| Average Basic Shares Outstanding | 11.21% | 0.85% | |||
| Average Diluted Shares Outstanding | 11.21% | 0.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||